Whenever I change my positions, the market makes a major move, suffers a “black swan” or reaches a key level, I stress test my portfolio by inflicting various scenarios upon it and analyzing the outcome. This is common practice and second nature for most hedge fund managers. In fact, the larger ones will use top-of-the-line
Mad Hedge Technology Letter April 24, 2024 Fiat Lux Featured Trade: (RUNNING ON FUMES) (ARKK), (NVDA), (ROKU), (TSLA)
This is a story of how important it is to accurately time the tech business cycle and to unload winners when they run dry. I am talking about Cathy Wood’s ARKK (ARKK) fund and how it has suddenly gone south with no savior in sight. The beginning of every tech innovation cycle is usually the
(WALL STREET IS PAYING ATTENTION TO THE METALS SECTOR) April 24, 2024 Hello everyone, Arizona Metals Corp. I’m diving into a Canadian gold explorer today that is only priced at $2.21. New drilling results from its Kay Mine Project, located 45 miles north of Phoenix, Arizona, suggest the presence of high-grade copper
Global Market Comments April 24, 2024 Fiat Lux Featured Trade: (THEY’RE NOT MAKING AMERICANS ANYMORE) (SPY), (EWJ), (EWL), (EWU), (EWG), (EWY), (FXI), (EIRL), (GREK), (EWP), (IDX), (EPOL), (TUR), (EWZ), (PIN), (EIS)
If demographics is destiny, then America’s future looks bleak. You see, they’re not making Americans anymore. At least that is the sobering conclusion of the latest Economist magazine survey of the global demographic picture. I have long been a fan of demographic investing, which creates opportunities for traders to execute on what I call “intergenerational
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Biotech and Healthcare Letter April 23, 2024 Fiat Lux Featured Trade: (A DRUG KINGPIN HIDING IN PLAIN SIGHT) (ABBV)
Have you ever thought about big pharma stocks as potential goldmines? I mean, we usually don’t gossip about the likes of AbbVie (ABBV) over lunch, but maybe we should. After all, those unassuming pharma giants could be hiding some serious potential for your portfolio. Let's dive into whether investing in AbbVie might just be your
Global Market Comments April 23, 2024 Fiat Lux Featured Trade: (WHY MOST SPAC’S ARE A SCAM) (DJT), (PSTH), (SPAK), (NKLA)